
Advertise on podcast: PeerVoice Brain & Behaviour Audio
This podcast has
71 episodes
Language
EnglishPublisher
PeerVoiceExplicit
No
Date created
2011/03/23
Latest episode
2026/10/30
Average duration
36 min.
Release period
25 days
Description
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Unlock PeerVoice Brain & Behaviour Audio podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from PeerVoice Brain & Behaviour Audio podcast
Cristina Granziera, MD, PhD / Jiwon Oh, MD, PhD, FRCPC - Recognising Progression Beyond Relapse: Clinical Challenges and Emerging Approaches in Progressive MS
2026/10/30
Cristina Granziera, MD, PhD / Jiwon Oh, MD, PhD, FRCPC - Recognising Progression Beyond Relapse: Clinical Challenges and Emerging Approaches in Progressive MS
Chongbo Zhao, MD - 探索不断变化的 CIDP 治疗格局:专家视角下的补体抑制疗法治疗潜力
2026/09/04
Chongbo Zhao, MD - 探索不断变化的 CIDP 治疗格局:专家视角下的补体抑制疗法治疗潜力
Jeffrey Weitz, MD, OC, FRCP(C) - Assessing the Potential of Factor XIa Inhibition for Secondary Stroke Prevention: Supporting Our Cross-Specialty Colleagues in Improving Patient Outcomes
2026/08/27
Jeffrey Weitz, MD, OC, FRCP(C) - Assessing the Potential of Factor XIa Inhibition for Secondary Stroke Prevention: Supporting Our Cross-Specialty Colleagues in Improving Patient Outcomes
Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic Advancement
2026/08/14
Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic Advancement
One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings
2026/07/20
One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare Settings
Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the Difference
2026/05/26
Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the Difference
Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke Prevention
2026/05/26
Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke Prevention
Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?
2026/04/30
Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?
Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa Inhibition
2026/04/29
Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa Inhibition
Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age Spectrum
2026/04/15
Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age Spectrum
Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?
2026/03/06
Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?
Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?
2026/01/07
Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?
Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health Impact
2025/12/17
Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health Impact
James F. Howard Jr, MD - Direct From San Francisco: Emerging Data and Expert Perspectives on Targeted Therapies for gMG
2025/11/21
James F. Howard Jr, MD - Direct From San Francisco: Emerging Data and Expert Perspectives on Targeted Therapies for gMG
Mike Sharma, MD, MSc, FRCPC - Challenging the Status Quo in Secondary Stroke Prevention: Current Perspectives on the Potential of Factor XIa Inhibition
2025/11/21
Mike Sharma, MD, MSc, FRCPC - Challenging the Status Quo in Secondary Stroke Prevention: Current Perspectives on the Potential of Factor XIa Inhibition
Podcast reviews
Read PeerVoice Brain & Behaviour Audio podcast reviews
Podcast sponsorship advertising
Start advertising on PeerVoice Brain & Behaviour Audio relevant audience podcasts
You may also like to advertise on these Podcasts

4.71325596
Bulwark Takes
The Bulwark

4.8583398
Didn't I Just Feed You
Stacie Billis and Meghan Splawn

4.4503509
Warfare
History Hit

4.8296932000
Fantasy Footballers - Fantasy Football Podcast
Fantasy Football

4.712851555
True Crime All The Time
Emash Digital

4.8160231996
Watch What Crappens
Ben Mandelker & Ronnie Karam

4.639261172
Modern Wisdom
Chris Williamson

4.66262310
True Crime with Kendall Rae
Mile Higher Media & Audioboom Studios

4.73454788
The Ancients
History Hit

4.89189317
The Why Files: Operation Podcast
The Why Files: Operation Podcast